These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2248156)

  • 1. The principles and practice of myoblast transfer.
    Karpati G
    Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the xmd dog in the assessment of myoblast transfer therapy.
    Cooper BJ
    Adv Exp Med Biol; 1990; 280():279-82; discussion 282-4. PubMed ID: 2248148
    [No Abstract]   [Full Text] [Related]  

  • 3. The dilemma of manifesting carriers in the context of myoblast transplantation.
    Kunkel LM
    Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149
    [No Abstract]   [Full Text] [Related]  

  • 4. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic and biochemical determinations in the pre-transplant workup and in the post-transplant assessment period.
    Worton RG; Bulman DE; Zubrzycka-Gaarn EE; Ray PN
    Adv Exp Med Biol; 1990; 280():219-25; discussion 225-6. PubMed ID: 2248141
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical aspects of myoblast implantation: investigations on two inherited myopathies in animals.
    Morgan JE
    Adv Exp Med Biol; 1990; 280():89-94; discussion 95-6. PubMed ID: 2248159
    [No Abstract]   [Full Text] [Related]  

  • 7. Myoblast transplantation in inherited myopathies.
    Morgan JE; Watt DJ
    Mol Cell Biol Hum Dis Ser; 1993; 3():303-31. PubMed ID: 8111544
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of muscle gene products in nuclear domains: does this constitute a problem for myoblast therapy?
    Blau HM; Pavlath GK; Rich K; Webster SG
    Adv Exp Med Biol; 1990; 280():167-72. PubMed ID: 2248136
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and proliferation of human myoblasts isolated with fluorescence activated cell sorting.
    Blau HM; Webster C; Pavlath GK
    Adv Exp Med Biol; 1990; 280():97-100. PubMed ID: 2248160
    [No Abstract]   [Full Text] [Related]  

  • 10. Plausible structural/functional/behavioral/biochemical transformations following myoblast transfer therapy.
    Law PK; Goodwin TG; Li HJ; Chen M
    Adv Exp Med Biol; 1990; 280():241-9; discussion 249-50. PubMed ID: 2248145
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues in myoblast transfer.
    Brooke MH
    Adv Exp Med Biol; 1990; 280():231-3. PubMed ID: 2248143
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.
    Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM
    Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy.
    Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH
    Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of quantitative myometry in the evaluation of myoblast transfer therapy.
    Munsat TL
    Adv Exp Med Biol; 1990; 280():227-9. PubMed ID: 2248142
    [No Abstract]   [Full Text] [Related]  

  • 15. Myogenic conversion of human non-muscle cells for the diagnosis and therapy of neuromuscular diseases.
    Miranda AF; Mongini T; Bonilla E; Miller AD; Wright WE
    Adv Exp Med Biol; 1990; 280():205-10. PubMed ID: 2248140
    [No Abstract]   [Full Text] [Related]  

  • 16. Myoblast transfer improves muscle genetics/structure/function and normalizes the behavior and life-span of dystrophic mice.
    Law PK; Goodwin TG; Li HJ; Ajamoughli G; Chen M
    Adv Exp Med Biol; 1990; 280():75-84; discussion 84-7. PubMed ID: 2248158
    [No Abstract]   [Full Text] [Related]  

  • 17. Invited review: myoblast transfer: a possible therapy for inherited myopathies?
    Partridge TA
    Muscle Nerve; 1991 Mar; 14(3):197-212. PubMed ID: 2041542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoblast transfer in DMD: problems in the interpretation of efficiency.
    Karpati G; Holland P; Worton RG
    Muscle Nerve; 1992 Oct; 15(10):1209-10. PubMed ID: 1406777
    [No Abstract]   [Full Text] [Related]  

  • 19. The fate of individual myoblasts after transplantation into muscles of DMD patients.
    Gussoni E; Blau HM; Kunkel LM
    Nat Med; 1997 Sep; 3(9):970-7. PubMed ID: 9288722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies.
    Mendell JR
    Adv Exp Med Biol; 1990; 280():287-95. PubMed ID: 2248150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.